Croissy-Beaubourg, October 31, 2018, 6:00pm CET – THERADIAG (ISIN: FR0004197747; Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, announces the appointment of Pierre Morgon as Chairman of the Board of Directors of…
Substantial growth in sales of Tracker kits for routine use: up 18% over first 9 months and up 34% in Q3 Croissy-Beaubourg, October 18, 2018, 6:00pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER) a company specializing in in…
Croissy-Beaubourg, October 9, 2018, 08:30am CEST – The Board of Directors of THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, announces the departure of Michel Finance, Theradiag’s Chief Executive Officer. He will…